Development and Validation of a Nomogram Model for Predicting the Risk of Readmission in Patients with Heart Failure with Reduced Ejection Fraction within 1 Year

被引:5
|
作者
Hu, Yue [1 ]
Wang, Xiaotong [2 ]
Xiao, Shengjue [3 ]
Huan, Chunyan [2 ]
Wu, Huimin [1 ]
Xu, Tao [2 ]
Guo, Minjia [2 ]
Zhu, Hong [2 ]
Pan, Defeng [2 ]
机构
[1] Xuzhou Med Univ, Dept Gen Practice, Affiliated Hosp, Xuzhou 221004, Jiangsu, Peoples R China
[2] Xuzhou Med Univ, Dept Cardiol, Affiliated Hosp, Xuzhou 221004, Jiangsu, Peoples R China
[3] Southeast Univ, Zhongda Hosp, Sch Med, Dept Cardiol, 87 Dingjiaqiao, Nanjing 210009, Jiangsu, Peoples R China
关键词
OUTCOMES; EPIDEMIOLOGY; MORTALITY; AGE; ASSOCIATION; DYSFUNCTION; MECHANISMS; CARDIOLOGY; IMPACT;
D O I
10.1155/2022/4143173
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The high incidence of readmission for patients with reduced ejection fraction heart failure (HFrEF) can seriously affect the prognosis. In this study, we aimed to build a simple predictive model to predict the risk of heart failure (HF) readmission in patients with HFrEF within one year of discharge from the hospital. This retrospective study enrolled patients with HFrEF evaluated in the Heart Failure Center of the Affiliated Hospital of Xuzhou Medical University from January 2018 to December 2020. The patients were allocated into the readmission or nonreadmission group, according to whether HF readmission occurred within 1 year of hospital discharge. Subsequently, all patients were randomly divided into training and validation sets in a 7 : 3 ratio. A nomogram was established according to the results of univariate and multivariate logistic regression analysis. Finally, the area under the receiver operating characteristic curve (AUC-ROC), calibration plot, and decision curve analysis (DCA) were used to validate the nomogram. Independent risk factors for HF readmission of patients with HFrEF within 1 year of hospital discharge were as follows: age, body mass index, systolic blood pressure, diabetes mellitus, left ventricular ejection fraction, and angiotensin receptor-neprilysin inhibitors. The AUC-ROC of the training and validation sets were 0.833 (95% confidence interval (CI): 0.793-0.866) and 0.794 (95% CI: 0.727-0.852), respectively, which have an excellent distinguishing ability. The predicted and observed values of the calibration curve also showed good consistency. DCA also confirmed that the nomogram had good clinical value. In conclusion, we constructed an accurate and straightforward nomogram model for predicting the 1-year HF readmission risk in patients with HFrEF. This nomogram can guide early clinical intervention and improve patient prognosis.
引用
收藏
页数:11
相关论文
共 50 条
  • [41] Heart failure with preserved ejection fraction in haemodialysis patients: prevalence, diagnosis, risk factors, prognosis
    Yu, Xixi
    Zhang, Di
    Chen, Jing
    Zhang, Han
    Shen, Ziyan
    Lv, Shiqi
    Wang, Yulin
    Huang, Xinhui
    Zhang, Xiaoyan
    Zhang, Chun
    ESC HEART FAILURE, 2023, 10 (05): : 2816 - 2825
  • [42] Evidence-based Therapy in Older Patients with Heart Failure with Reduced Ejection Fraction
    Stolfo, Davide
    Sinagra, Gianfranco
    Savarese, Gianluigi
    CARDIAC FAILURE REVIEW, 2022, 8
  • [43] Cost-effectiveness of Dapagliflozin for Treatment of Patients With Heart Failure With Reduced Ejection Fraction
    Parizo, Justin T.
    Goldhaber-Fiebert, Jeremy D.
    Salomon, Joshua A.
    Khush, Kiran K.
    Spertus, John A.
    Heidenreich, Paul A.
    Sandhu, Alexander T.
    JAMA CARDIOLOGY, 2021, 6 (08) : 926 - 935
  • [44] Timing of acute decompensated heart failure in patients with heart failure and mildly reduced ejection fraction
    Steffen, Henning Johann
    Abel, Noah
    Lau, Felix
    Schmitt, Alexander
    Reinhardt, Marielen
    Akin, Muharrem
    Bertsch, Thomas
    Rusnak, Jonas
    Weidner, Kathrin
    Behnes, Michael
    Akin, Ibrahim
    Schupp, Tobias
    HEART AND VESSELS, 2025,
  • [45] Heart failure with mildly reduced ejection fraction: retrospective study of ejection fraction trajectory risk
    Miller, Robert J. H.
    Nabipoor, Majid
    Youngson, Erik
    Kotrri, Gynter
    Fine, Nowell M.
    Howlett, Jonathan G.
    Paterson, Ian D.
    Ezekowitz, Justin
    McAlister, Finlay A.
    ESC HEART FAILURE, 2022, 9 (03): : 1564 - 1573
  • [46] Medical Management of Heart Failure With Reduced Ejection Fraction in Patients With Advanced Renal Disease
    Hein, Aaron M.
    Scialla, Julia J.
    Edmonston, Daniel
    Cooper, Lauren B.
    DeVore, Adam D.
    Mentz, Robert J.
    JACC-HEART FAILURE, 2019, 7 (05) : 371 - 382
  • [47] Risk factors for rehospitalization in heart failure with preserved ejection fraction compared with reduced ejection fraction
    Setoguchi, Masahiko
    Hashimoto, Yuji
    Sasaoka, Taro
    Ashikaga, Takashi
    Isobe, Mitsuaki
    HEART AND VESSELS, 2015, 30 (05) : 595 - 603
  • [48] Cigarette Smoking, Cessation, and Risk of Heart Failure With Preserved and Reduced Ejection Fraction
    Ding, Ning
    Shah, Amil M.
    Blaha, Michael J.
    Chang, Patricia P.
    Rosamond, Wayne D.
    Matsushita, Kunihiro
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2022, 79 (23) : 2298 - 2305
  • [49] Benefits of a comprehensive care model in patients with heart failure and preserved ejection fraction: The UMIPIC program
    Cerqueiro-Gonzalez, J. M.
    Gonzalez-Franco, A.
    Carrascosa-Garcia, S.
    Soler-Rangel, L.
    Ruiz-Laiglesia, F. J.
    Epelde-Gonzalo, F.
    Davila-Ramos, M. F.
    Casado-Cerrada, J.
    Casariego-Vales, E.
    Manzano, L.
    REVISTA CLINICA ESPANOLA, 2022, 222 (06): : 339 - 347
  • [50] Relation of Elevated Heart Rate in Patients With Heart Failure With Reduced Ejection Fraction to One-Year Outcomes and Costs
    DeVore, Adam D.
    Schulte, Phillip J.
    Mentz, Robert J.
    Hardy, N. Chantelle
    Kelly, Jacob P.
    Velazquez, Eric J.
    Maya, Juan F.
    Kielhorn, Adrian
    Patel, Harshali K.
    Reed, Shelby D.
    Hernandez, Adrian F.
    AMERICAN JOURNAL OF CARDIOLOGY, 2016, 117 (06) : 946 - 951